[1]Locationinpatent:experimentalpartMallari,JeremyP.;Shelat,AnangA.;Kosinski,Aaron;Caffrey,ConorR.;Connelly,Michele;Zhu,Fangyi;McKerrow,JamesH.;KiplinGuy[JournalofMedicinalChemistry,2009,vol.52,#20,p.6489-6493]
870718-00-6
870718-01-7
848779-86-2
352525-82-7
352525-80-5
480425-34-1
869718-81-0 | 3,6,9,12,15,18,21,24-Octaoxapentacosan-1-amine | AA004O0M | MFCD13184961
871329-69-0 | 4-(Thiomorpholinylsulfonyl)phenylboronic acid | AA004OQI | MFCD07363757
850567-41-8 | N-(3-Bromopropyl) 4-Boronobenzamide | AA004P9M | MFCD06659891
859833-21-9 | 3-(Piperidin-1-ylmethyl)phenylboronic acid, pinacol ester | AA004Q1I | MFCD08435871
84804-69-3 | 5-(Chloromethyl)-1,3-dimethyl-1H-1,2,4-triazole | AA004QV0 | MFCD13806380
83852-56-6 | Chrysomycin B | AA004RS9 | MFCD07370132
850567-21-4 | 3-(N-Ethylaminocarbonyl)phenylboronic acid | AA004SFQ | MFCD04115689
866783-13-3 | (1S)-4,5-Dimethoxy-1-[(methylamino)methyl]benzocyclobutane HCl | AA004TA6 | MFCD13194843
865998-46-5 | Ethyl 5-nitro-1h-imidazole-2-carboxylate | AA004TYB | MFCD19442194
85274-48-2 | 6-Bromo-2-chloro-3-phenylquinoline | AA004UWB | MFCD09997952